For decades, a major bottleneck in cancer research has been the difficulty of discovering genes and pathways underlying tumorigenesis. This has changed markedly with the advent of array-based ...

For many years, molecular diagnostics laboratories have been expanding the tests that they offer in the area of disease-targeted clinical sequencing. Early on, sequencing tests were available only for ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...